Companies

Immunome Inc. (IMNM) SEC filings

CIK 0001472012 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2022
Revenue (USD)6.9 M14.0 M
Net income (USD)-106.8 M-36.9 M-24.7 M
Diluted EPS (USD/shares)-2.43-5.38-3.09

Latest filings

FiledFormDescriptionPeriod
2026-10-058-K8-K items 1.01,3.02,9.012026-10-02
2026-09-15442026-09-11
2026-09-11144144
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-12442026-08-10
2026-08-12144144
2026-08-11S-8S-8
2026-08-1110-Q10-Q2026-06-30
2026-08-118-K8-K items 2.02,9.012026-08-11
2026-08-10442026-08-06
2026-08-06442026-08-04
2026-08-06144144
2026-08-04144144
2026-07-27442026-07-23
2026-07-27442026-07-23
2026-07-27442026-07-23
2026-07-27442026-07-23
2026-07-27442026-07-23
2026-07-27442026-07-23
2026-07-27442026-07-23
2026-07-09442026-07-07
2026-07-07442026-07-06
2026-07-07442026-07-02
2026-07-07144144

Forms on file (last 1,000): 4 156, 8-K 82, 3 30, 10-Q 18, 144 17, SCHEDULE 13G/A 14, SC 13G/A 13, SC 13G 13. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=IMNM (0.002 USD), /gw/filings/filings?ticker=IMNM&form=8-K, /gw/filings/facts?ticker=IMNM&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange